$ENDV

NDONOVO THERAPEUTICS INC

Electromedical equipment · OTCID

0.000 -100.00% as of 10/28/2026, 3:29:38 PM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $ENDV. Be the first to post.

SEC STAFF ACTION Thu Sep 19 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
15-12G Fri Feb 02 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
8-K Wed Jan 03 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
10-Q Fri Dec 29 2023 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
10-Q/A Fri Dec 29 2023 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
8-K Mon Dec 04 2023 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
NT 10-Q Wed Nov 15 2023 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
8-K Thu Oct 12 2023 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View

All filings

revenue 9/8/2026 Revenue reported: $135.4K, year ended Dec 31, 2022
revenue 9/8/2026 Revenue reported: $73.1K, year ended Dec 31, 2021
revenue 9/8/2026 Revenue reported: $165.8K, year ended Dec 31, 2020
revenue 9/8/2026 Revenue reported: $310.2K, year ended Dec 31, 2019
revenue 9/8/2026 Revenue reported: $83.3K, year ended Dec 31, 2018
revenue 9/8/2026 Revenue reported: $1.5K, quarter ended Sep 30, 2023
revenue 9/8/2026 Revenue reported: $45.2K, quarter ended Jun 30, 2023
revenue 9/8/2026 Revenue reported: $87.5K, quarter ended Mar 31, 2023
revenue 9/8/2026 Revenue reported: $121.5K, quarter ended Dec 31, 2022 (derived)
revenue 9/8/2026 Revenue reported: $11.0K, quarter ended Sep 30, 2022

–

No resolved statements yet.

Quarterly

Annual

Source: SEC XBRL

$850K (FY 2022) · 6.3x revenue

Alan (current CEO) - $1.6M total disclosed since 2017

Alan

Provisional - extracted from filings, not verified.

Provisional - extracted from filings, not verified.

IN DEFAULT · $7.0M in arrears
$400K matured Sep 30, 2022 10% 10-Q · 2023-12-29

Quote

The holder of the promissory note can convert the outstanding unpaid principal and accrued interest at a fixed conversion rate, subject to standard anti-dilution features, six-month after issuance date .
$4.6M matured Sep 30, 2022 10-Q · 2023-12-29

Quote

Variable-rate notes The gross amount of all convertible notes with variable conversion rates outstanding as of September 30, 2022, is $ 4,607,100 , which are all past maturity.
$1.9M matured Sep 30, 2022 10-Q · 2023-12-29

Quote

As of September 30, 2022, the Company has eighteen (18) fixed-rate promissory notes with an outstanding balance of $ 1,920,900 , of which $ 1,045,900 are past maturity.
$77K matured Sep 30, 2023 10-Q · 2023-12-29

Quote

Variable-rate notes During the nine months ended September 30, 2023, the Company executed a settlement agreement with one investor to extinguish the remaining principal balance of a promissory note into 4,300,590 shares of common stock, which resulted in a gain from debt extinguishment of approximately $ 77,000 .
NEARING / AGED
$1.3M — 10-Q · 2023-12-29

Quote

During the nine months ended September 30, 2022, the Company issued 3,100,000 shares of common stock as commitment shares in connection with promissory notes.
No notes match this filter.

No resolved predictions on $ENDV yet.

Nothing awaiting resolution.